Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil once daily for urodynamic effects in men with benign prostatic hyperplasia
2007-004321-15Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in benign prostatic hyperplasia (BPH) comparing Tadalafil with Placebo (2 arms). Primary endpoint: Detrusor pressure at maximum flow rate. Started Oct 2007; status: completed.
02
Drugs
tadalafil
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on 2007-004321-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004321-15.